Cover Image
市場調查報告書

多血小板血漿的全球市場測 2014-2020年 (純粹的多血小板血漿,多白血球、多血小板血漿,多白血球、多血小板纖維蛋白)

Platelet Rich Plasma Market (By Types, By Origin, By Applications) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast 2014 - 2020

出版商 Transparency Market Research 商品編碼 326014
出版日期 內容資訊 英文 102 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
多血小板血漿的全球市場測 2014-2020年 (純粹的多血小板血漿,多白血球、多血小板血漿,多白血球、多血小板纖維蛋白) Platelet Rich Plasma Market (By Types, By Origin, By Applications) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast 2014 - 2020
出版日期: 2015年01月30日 內容資訊: 英文 102 Pages
簡介

多血小板血漿(PRP),是將血小板從通常的4倍提高到8倍濃度的 產品化血漿,以「血小板等離子凝膠」等名稱利用於整形外科、運動醫學、神經外科、心胸外科等各種領域的障礙治療,在美容產業也廣泛活躍著。

本報告以多血小板血漿的全球市場為焦點為焦點,提供考察現狀與今後潛力所需的,全球整體及各地區的交易規模的變化分析與預測、市場推動與阻礙因素、發展機會、產業價值鏈、競爭環境、市場向心力等的相關分析資訊、主要加入企業簡介彙整。

第1章 序

第2章 摘要整理

  • 市場簡述:多血小板血漿的全球市場
  • 多血小板血漿的全球市場 - 各形式(單位:100萬美元)
  • 多血小板血漿的全球市場 - 各產生源(單位:100萬美元)
  • 多血小板血漿的全球市場 - 各用途(單位:100萬美元)
  • 比較分析:多血小板血漿的全球市場 - 各地區(金額成長率)

第3章 市場概要:多血小板血漿的全球市場

  • 簡介和市場定義
  • 活動影響分析
  • 市場動態
    • 市場推動要素
      • 整形外科、運動障礙的頻繁和伴隨的外科手術增加使市場活絡
      • 美容整形手術增加使市場趨向加速
      • 技術進步和新型設備認證是全世界的順風
      • 由於新興地區對多血小板血漿產品、設備的認識擴大預期市場成長
    • 阻礙市場要素
      • 高額的產品、設備成本市場成長的腳鐐
      • 可能妨礙市場成長的手術失敗與疾病流傳(使用同種異體血、同源血的狀況)
    • 機會
      • 尖端技術設備及新應用領域的開發將開闢新途徑
  • 多血小板血漿(PRP)全球市場的波特五力分析
  • 價值鏈分析
  • 法規情形
  • 市場向心力分析:多血小板血漿(PRP)的全球市場 - 各地區
  • 競爭環境
    • 多血小板血漿(PRP)全球市場佔有率分析 - 各主要企業(金額組合比例)

第4章 多血小板血漿(PRP)的全球市場 - 各形式

  • 概要
    • 全球市場收入 - 各形式(單位:100萬美元)
  • 純粹多血小板血漿(P-PRP)
  • 多白血球、多血小板血漿(L-PRP)
  • 純粹多血小板纖維蛋白(L-PRF)及多白血球、多血小板纖維蛋白(L-PRF)

第5章 多血小板血漿(PRP)的全球市場 - 各產生源

  • 概要
    • 全球市場收入 - 各產生源(單位:100萬美元)
  • 自體血多血小板血漿
  • 同種異體血多血小板血漿
  • 同源血多血小板血漿

第6章 多血小板血漿(PRP)的全球市場 - 各用途

  • 概要
    • 全球市場收入 - 各用途(單位:100萬美元)
  • 整形外科
  • 美容外科
  • 一般外科
  • 神經外科
  • 其他外科手術(泌尿科、心胸外科、口腔下巴顏面外科、牙周科)

第7章 多血小板血漿(PRP)的全球市場 - 各地區

  • 概要
    • 全球市場收入 - 各地區(單位:100萬美元)
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第8章 建議

  • 新對興市場的投資打開擴大市場佔有率的新道路
  • 新多血小板血漿設備的開發與新應用領域的發現加速市場成長
  • 活絡市場成長的先進技術多血小板血漿設備的商業化及推動

第9章 企業簡介(企業概要、財務概況、產品系列、產業策略、最新發展)

  • AdiStem Ltd.
  • Arteriocyte Medical Systems, Inc.
  • Arthrex, Inc.
  • Biomet, Inc.
  • Cesca Therapeutics, Inc.
  • DePuy Synthes, Inc. (DePuy Mitek Sports Medicine)
  • Dr. PRP America LLC
  • EmCyte Corporation
  • Exactech, Inc.
  • Harvest Technologies Corp.
  • Nuo Therapeutics, Inc. (Cytomedix, Inc.)
  • Regen Lab SA
  • Stryker Corporation
目錄

Platelet rich plasma (PRP) is a blood plasma product in which concentration of platelets is elevated four to eight times than normal blood platelet concentration. PRP is also called platelet rich gel, platelet enriched plasma and platelet enriched gel. PRP is an effective treatment to treat various diseases such as orthopedic diseases, sports injuries, neurological diseases and cardiothoracic diseases. In addition, PRP therapy has an extensive application in cosmetic industry. This report studies the current scenario as well as future market potential for PRP globally.

The market overview section of the report comprises qualitative analysis of the overall PRP market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter's five force analysis and market attractiveness analysis. In addition, various analyses such as event impact analysis, regulatory scenario and value chain analysis has also been provided. Event impact analysis encompasses the major events occurred in past decade and are expected to occur during the forecast period and are likely to affect the market dynamics positively or negatively. Value chain analysis includes the study of major steps involved in the PRP devices preparation and distribution. Regulatory scenario includes the study of different regulatory norms and procedures that regulate the approval and commercialization of PRP devices and products.

The global PRP market has been segmented on the basis of types, origins and applications. On the basis of types, the global PRP market is categorized as pure-PRP (P-PRP), leukocyte-rich PRP (L-PRP) and pure PRF/leukocyte-rich PRF (L-PRF). Moreover, on the basis of origin, the PRP market has been segmented into autologus, homologus and allogenic PRP. Furthermore, on the basis of applications, the global PRP market has been classified as neurosurgery, cosmetic surgery, orthopedic surgery, general surgery and others (cardiothoracic surgery, urology, periodontal surgery and oral and maxillofacial surgery). The market for these types, origins and applications has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, geographic presence and technological developments. The market size and forecast in terms of revenue (USD million) for each of these segments have been provided for the period 2012 to 2020, considering 2013 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2014 to 2020.

Geographically, the PRP market has been classified into four segments namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region has been provided for the period 2012 to 2020, in terms of origin, types and applications, along with the CAGR (%) for the forecast period 2014 to 2020.

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global PRP market, in terms of percentage share in 2013 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. The report concludes with the profiles of major players in the global PRP market such as AdiStem Ltd., Arteriocyte Medical Systems, Inc., Arthrex, Inc., Biomet, Inc., Cesca Therapeutics, Inc., DePuy Synthes, Inc., Dr. PRP America LLC., EmCyte Corporation, Exactech, Inc., Harvest Technologies Corp., Nuo Therapeutics, Inc., Regen Lab SA, and Stryker Corporation. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.

Global Platelet Rich Plasma (PRP) Market is segmented as follows:

Global Platelet Rich Plasma (PRP) Market, by Types

  • Pure-Platelet Rich Plasma (P-PRP)
  • Leukocyte-Platelet Rich Plasma (L-PRP)
  • Leukocyte-Platelet Rich Fibrin (L-PRF)

Global Platelet Rich Plasma (PRP) Market, by Origin

  • Autologus
  • Homologus
  • Allogenic

Global Platelet Rich Plasma (PRP) Market, by Applications

  • Orthopedic Surgery
  • Cosmetic Surgery
  • General Surgery
  • Neurosurgery
  • Other Surgeries (Oral and Maxillofacial, Cardiothoracic, Periodontal and Urological)

Global Platelet Rich Plasma (PRP) Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 Preface

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
    • 1.3.1 Sources
      • 1.3.1.1 Secondary Research
      • 1.3.1.2 Primary Research
    • 1.3.2 Assumptions

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global PRP Market (2013 & 2020)
  • 2.2 Global PRP Market, by Types, 2013 (USD Million)
  • 2.3 Global PRP Market, by Origin, 2013 (USD Million)
  • 2.4 Global PRP Market, by Applications, 2013 (USD Million)
  • 2.5 Comparative Analysis: Global PRP Market, By Geography, 2013 & 2020 (Value %)

Chapter 3 Market Overview: Platelet Rich Plasma Market

  • 3.1 Introduction and Market Definition
  • 3.2 Event Impact Analysis
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 Increase in prevalence of orthopedic diseases and sports injuries and thereby rise in number of surgeries fuel market growth
      • 3.3.1.2 Increasing cosmetic surgeries are likely to accelerate market growth
      • 3.3.1.3 Technological advancements and regulatory approvals for new devices are contributing to the growth of the global PRP market
      • 3.3.1.4 Increasing awareness about PRP products and devices in emerging economies would accelerate market growth
    • 3.3.2 Market Restraints
      • 3.3.2.1 High cost of PRP products and devices would restrain market growth
      • 3.3.2.2 Threat of therapy failure and disease transfer (in case of allogenic and homologus PRP) could offer the resistance to market growth
    • 3.3.3 Opportunities
      • 3.3.3.1 Development of technologically advanced devices and new application areas of PRP technology would open new avenues
  • 3.4 Porters Five Force Analysis for the Global Platelet Rich Plasma (PRP) Market
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Threat of Substitutes
    • 3.4.4 Threat of New Entrants
    • 3.4.5 Competitive Rivalry
  • 3.5 Value Chain Analysis
  • 3.6 Regulatory Scenario
  • 3.7 Market Attractiveness Analysis: Global Platelet Rich Plasma (PRP) Market, by Geography, 2013
  • 3.8 Competitive Landscape
    • 3.8.1 Global PRP Market Share Analysis, by Key Players, 2013 (Value %)

Chapter 4 Global Platelet-Rich Plasma Market, by Types

  • 4.1 Overview
    • 4.1.1 Global PRP Market Revenue, by Types, 2012 - 2020 (USD Million)
  • 4.2 Pure Platelet-Rich Plasma (P-PRP)
    • 4.2.1 Global Pure Platelet-Rich Plasma Market Revenue, 2012 - 2020, (USD Million)
  • 4.3 Leukocyte-Rich Platelet-Rich Plasma (L-PRP)
    • 4.3.1 Global Leukocyte-Rich Platelet Rich Plasma Market Revenue, 2012 - 2020, (USD Million)
  • 4.4 Pure Platelet-Rich Fibrin (P-PRF)/ Leukocyte-Rich Platelet-Rich Fibrin (L-PRF)
    • 4.4.1 Global Leukocyte-Rich Platelet Rich Fibrin Market Revenue, 2012 - 2020, (USD Million)

Chapter 5 Global Platelet-Rich Plasma Market, by Origin

  • 5.1 Overview
    • 5.1.1 Global PRP Market Revenue, by Origin, 2012 - 2020 (USD Million)
  • 5.2 Autologus Platelet-Rich Plasma
    • 5.2.1 Global Autologus Platelet-Rich Plasma Market Revenue, 2012 - 2020, (USD Million)
  • 5.3 Allogenic Platelet-Rich Plasma
    • 5.3.1 Global Allogenic Platelet-Rich Plasma Market Revenue, 2012 - 2020, (USD Million)
  • 5.4 Homologus Platelet-Rich Plasma
    • 5.4.1 Global Homologus Platelet-Rich Plasma Market Revenue, 2012 - 2020, (USD Million)

Chapter 6 Global Platelet-Rich Plasma Market, by Applications

  • 6.1 Overview
    • 6.1.1 Global PRP Market Revenue, by Applications, 2012 - 2020 (USD Million)
  • 6.2 Orthopedic Surgery
    • 6.2.1 Global Orthopedic Surgery Market Revenue, 2012 - 2020, (USD Million)
  • 6.3 Cosmetic Surgery
    • 6.3.1 Global Cosmetic Surgery Market Revenue, 2012 - 2020, (USD Million)
  • 6.4 General Surgery
    • 6.4.1 Global General Surgery Market Revenue, 2012 - 2020, (USD Million)
  • 6.5 Neurosurgery
    • 6.5.1 Global Neurosurgery Market Revenue, 2012 - 2020, (USD Million)
  • 6.6 Other Surgeries (Urology, Cardiothoracic, Oral & Maxillofacial and Periodontal)
    • 6.6.1 Global Other Surgeries Market Revenue, 2012 - 2020, (USD Million)

Chapter 7 Global Platelet Rich Plasma Market, by Geography

  • 7.1 Overview
    • 7.1.1 Global PRP Market Revenue, by Geography, 2012 - 2020 (USD Million)
  • 7.2 North America
    • 7.2.1 North America PRP Market, by Types, 2012 - 2020 (USD Million)
    • 7.2.2 North America PRP Market, by Origin, 2012 - 2020 (USD Million)
    • 7.2.3 North America PRP Market, by Applications, 2012 - 2020 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe PRP Market, by Types, 2012 - 2020 (USD Million)
    • 7.3.2 Europe PRP Market, by Origin, 2012 - 2020 (USD Million)
    • 7.3.3 Europe PRP Market, by Applications, 2012 - 2020 (USD Million)
  • 7.4 Asia-Pacific
    • 7.4.1 Asia-Pacific PRP Market, by Types, 2012 - 2020 (USD Million)
    • 7.4.2 Asia-Pacific PRP Market, by Origin, 2012 - 2020 (USD Million)
    • 7.4.3 Asia-Pacific PRP Market, by Applications, 2012 - 2020 (USD Million)
  • 7.5 Rest of the World (RoW)
    • 7.5.1 RoW PRP Market, by Types, 2012 - 2020 (USD Million)
    • 7.5.2 RoW PRP Market, by Origin, 2012 - 2020 (USD Million)
    • 7.5.3 RoW PRP Market, by Applications, 2012 - 2020 (USD Million)

Chapter 8 Recommendations

  • 8.1 Investment in emerging markets would open new avenues to accentuate market share
  • 8.2 Development of new PRP devices and discovery of new application areas would fuel market growth
  • 8.3 Commercialization and promotion of technologically advanced PRP devices to boost market growth

Chapter 9 Company Profiles

  • 9.1 AdiStem Ltd.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Overview
    • 9.1.3 Product Portfolio
    • 9.1.4 Business Strategies
    • 9.1.5 Recent Developments
  • 9.2 Arteriocyte Medical Systems, Inc.
    • 9.2.1 Company Overview
    • 9.2.2 Financial Overview
    • 9.2.3 Product Portfolio
    • 9.2.4 Business Strategies
    • 9.2.5 Recent Developments
  • 9.3 Arthrex, Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Overview
    • 9.3.3 Product Portfolio
    • 9.3.4 Business Strategies
    • 9.3.5 Recent Developments
  • 9.4 Biomet, Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Overview
    • 9.4.3 Product Portfolio
    • 9.4.4 Business Strategies
    • 9.4.5 Recent Developments
  • 9.5 Cesca Therapeutics, Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Overview
    • 9.5.3 Product Portfolio
    • 9.5.4 Business Strategies
    • 9.5.5 Recent Developments
  • 9.6 DePuy Synthes, Inc. (DePuy Mitek Sports Medicine)
    • 9.6.1 Company Overview
    • 9.6.2 Financial Overview
    • 9.6.3 Product Portfolio
    • 9.6.4 Business Strategies
    • 9.6.5 Recent Developments
  • 9.7 Dr. PRP America LLC
    • 9.7.1 Company Overview
    • 9.7.2 Financial Overview
    • 9.7.3 Product Portfolio
    • 9.7.4 Business Strategies
    • 9.7.5 Recent Developments
  • 9.8 EmCyte Corporation
    • 9.8.1 Company Overview
    • 9.8.2 Financial Overview
    • 9.8.3 Product Portfolio
    • 9.8.4 Business Strategies
    • 9.8.5 Recent Developments
  • 9.9 Exactech, Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Financial Overview
    • 9.9.3 Product Portfolio
    • 9.9.4 Business Strategies
    • 9.9.5 Recent Developments
  • 9.10 Harvest Technologies Corp.
    • 9.10.1 Company Overview
    • 9.10.2 Financial Overview
    • 9.10.3 Product Portfolio
    • 9.10.4 Business Strategies
    • 9.10.5 Recent Developments
  • 9.11 Nuo Therapeutics, Inc. (Cytomedix, Inc.)
    • 9.11.1 Company Overview
    • 9.11.2 Financial Overview
    • 9.11.3 Product Portfolio
    • 9.11.4 Business Strategies
    • 9.11.5 Recent Developments
  • 9.12 Regen Lab SA
    • 9.12.1 Company Overview
    • 9.12.2 Financial Overview
    • 9.12.3 Product Portfolio
    • 9.12.4 Business Strategies
    • 9.12.5 Recent Developments
  • 9.13 Stryker Corporation
    • 9.13.1 Company Overview
    • 9.13.2 Financial Overview
    • 9.13.3 Product Portfolio
    • 9.13.4 Business Strategies
    • 9.13.5 Recent Developments

List of Figures

  • FIG. 1 Market Segmentation : Platelet Rich Plasma (PRP) Market
  • FIG. 2 Global PRP Market, by Types, 2013 (USD Million)
  • FIG. 3 Global PRP Market, by Origin, 2013 (USD Million)
  • FIG. 4 Global PRP Market, by Applications, 2013 (USD Million)
  • FIG. 5 Comparative Analysis: Global PRP Market, by Geography, 2013 & 2020 (Value %)
  • FIG. 6 Porter's Five Forces Analysis: Global Platelet Rich Plasma (PRP) Market
  • FIG. 7 Value Chain Analysis for Platelet Rich Plasma Market
  • FIG. 8 Market Attractiveness Analysis: Global Platelet Rich Plasma Market, by Geography, 2013
  • FIG. 9 Global PRP Market Share Analysis, by Key Players, 2013 ( Value %)
  • FIG. 10 Global Pure Platelet-Rich Plasma Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 11 Global Leukocyte- Rich Platelet Rich Plasma Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 12 Global Leukocyte- Rich Platelet Rich Fibrin Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 13 Global Autologus Platelet-Rich Plasma Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 14 Global Allogenic Platelet-Rich Plasma Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 15 Global Homologus Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 16 Global Orthopedic Surgery Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 17 Global Cosmetic Surgery Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 18 Global General Surgery Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 19 Global Neurosurgery Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 20 Global Other Surgeries Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 21 Biomet, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 22 Cesca Therapeutics, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 23 Exactech, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 24 Nuo Therapeutics, Inc. (Cytomedix, Inc.): Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 25 Stryker Corporation: Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: Global PRP Market (2013 & 2020)
  • TABLE 2 Global PRP Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 3 Global PRP Market Revenue, by Origin, 2012 - 2020 (USD Million)
  • TABLE 4 Global PRP Market Revenue, by Applications, 2012 - 2020 (USD Million)
  • TABLE 5 Global PRP Market Revenue, by Geography, 2012 - 2020 (USD Million)
  • TABLE 6 North America PRP Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 7 North America PRP Market Revenue, by Origin, 2012 - 2020 (USD Million)
  • TABLE 8 North America PRP Market Revenue, by Applications, 2012 - 2020 (USD Million)
  • TABLE 9 Europe PRP Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 10 Europe PRP Market Revenue, by Origin, 2012 - 2020 (USD Million)
  • TABLE 11 Europe PRP Market Revenue, by Applications, 2012 - 2020 (USD Million)
  • TABLE 12 Asia-Pacific PRP Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 13 Asia-Pacific PRP Market Revenue, by Origin, 2012 - 2020 (USD Million)
  • TABLE 14 Asia-Pacific PRP Market Revenue, by Applications, 2012 - 2020 (USD Million)
  • TABLE 15 RoW PRP Market Revenue, by Types, 2012 - 2020 (USD Million)
  • TABLE 16 RoW PRP Market Revenue, by Origin, 2012 - 2020 (USD Million)
  • TABLE 17 RoW PRP Market Revenue, by Applications, 2012 - 2020 (USD Million)
Back to Top